Target intelligence / Profile preview

Bordetella bronchiseptica

Molecular classification
Other (Gram-negative bacterium)
01

Overview

Bordetella bronchiseptica is a small, Gram-negative, aerobic, motile, rod-shaped bacterium commonly found in the respiratory tract of animals, especially dogs and cats, where it causes highly contagious respiratory disease (kennel cough in dogs, bordetellosis in cats); it can persist in the environment for extended periods and rarely causes infections in humans, primarily infecting the immunocompromised. Its pathogenicity is due to a suite of virulence factors (adhesins such as filamentous hemagglutinin, fimbriae, pertactin; toxins like dermonecrotic toxin; flagella), and its expression of virulence genes is tightly regulated by the BvgAS two-component regulatory system

Other names
Bordetella bronchisepticaB. bronchiseptica
02

Mechanism of action

Inhibition of bacterial cell wall synthesis (by certain β-lactams), inhibition of protein synthesis (by tetracyclines and aminoglycosides), lytic activity (by bacteriophages)

03

Biological functions

Infectioncolonizationimmune evasionpathogenesis
04

Disease associations

Infection (especially respiratory infections in animals, rarely in humans)
05

Safety considerations

Antibiotic resistancezoonotic transmissionpersistence in the environmentinadequate response to macrolides and β-lactams
06

Interacting drugs

Antibiotics (such as tetracyclines, aminoglycosides, some cephalosporins)

1 more in the full profile.

07

Biomarkers

Detection by PCR targeting specific bacterial genes (such as flagellin gene); no standard host-based biomarkers used clinically

Beyond the preview

Go deeper on Bordetella bronchiseptica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bordetella bronchiseptica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call